Deepak Fertilis.
Deepak Fertilisers & Petrochemicals Corp Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.
From Deepak Fertilis.'s Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28.
- Revenue uplift expected from capacity addition is calculable using shared average realizations and known production quantities.
- Growth will be driven by multiple levers: downstream expansion (DMSL), premiumization in crop nutrition and specialty fertilizers, and increasing specialty industrial chemicals.
- Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions.
- Integration benefits from the long-term LNG contract with Equinor and improved ammonia plant utilization will provide cost advantages and support margin stability.
2 more points from Deepak Fertilis.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Deepak Fertilis. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27:
- Gopalpur TAN plant (ammonium nitrate)
- Dahej nitric acid plant
- These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.
- The company has capitalized interest costs related to these projects, indicating ongoing investment.
- The new capacities will bolster integrated supply chain benefits, improve operating leverage, and drive the next growth phase.
- Management is also evaluating strategic options for the DMSL subsidiary, including IPO or demerger, to unlock value.
2 more points from Deepak Fertilis.'s call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Deepak Fertilis. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Deepak Fertilis.'s call on order book
Create a free account to keep reading this call
Deepak Fertilis. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹3.3K Cr, net profit ₹490 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Deepak Fertilisers & Petrochemicals Corp Ltd's management said in earlier quarters
- Q3 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Deepak Fertilis. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Deepak Fertilis. Q1 FY27 results?
New capacities at Gopalpur (TAN) and Dahej (acids) coming on stream will contribute to revenue growth starting Q3/Q4 FY27 and will achieve near-optimum utilization by FY28. The company is entering the next phase of growth with new capacities (Gopalpur TAN and Dahej nitric acid projects) commissioning in Q2 FY27, expected to contribute from Q3/Q4 FY27 onwards.
What is Deepak Fertilis. share price analysis?
Deepak Fertilis. currently shows a below-average growth signal. The stock trades at a P/E of 17.2 with a market cap of ₹16,968 Cr. Investors should review the full earnings analysis for detailed insights.
Is Deepak Fertilis. planning capital expenditure?
Two major capex projects are in the final stage of commissioning and expected to be operational by end of Q3 FY27: - Gopalpur TAN plant (ammonium nitrate) - Dahej nitric acid plant - These new capacities are expected to start contributing to revenue and EBITDA from Q3/Q4 FY27, with ramp-up possibly reaching around 80% utilization by Q4.
Keep Deepak Fertilis. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
